PROGENICS PHARMACEUTICALS IN - COM (PGNX)

CUSIP: 743187106

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / COM
Total 13F shares
58,932,312
Share change
-1,579,056
Total reported value
$248,849,563
Put/Call ratio
2080%
Price per share
$4.22
Number of holders
99
Value change
-$6,973,074
Number of buys
40
Number of sells
60

Quarterly Holders Quick Answers

What is CUSIP 743187106?
CUSIP 743187106 identifies PGNX - PROGENICS PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROGENICS PHARMACEUTICALS IN - COM (PGNX) as of Q2 2016

As of 30 Jun 2016, PROGENICS PHARMACEUTICALS IN - COM (PGNX) was held by 99 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 58,932,312 shares. The largest 10 holders included FEDERATED INVESTORS INC /PA/, Broadfin Capital, LLC, BAKER BROS. ADVISORS LP, FMR LLC, PINNACLE ASSOCIATES LTD, VANGUARD GROUP INC, BlackRock Fund Advisors, TUDOR INVESTMENT CORP ET AL, MILLENNIUM MANAGEMENT LLC, and STATE STREET CORP. This page lists 99 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.